Cargando…
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity affecting patients with severe pulmonary abnormalities treated in intensive care units. Delays in diagnosis contribute to a delayed start of antifungal therapy. In addition, the emergence of resistance to triaz...
Autores principales: | Meijer, Eelco F. J., Dofferhoff, Anton S. M., Hoiting, Oscar, Buil, Jochem B., Meis, Jacques F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344504/ https://www.ncbi.nlm.nih.gov/pubmed/32517166 http://dx.doi.org/10.3390/jof6020079 |
Ejemplares similares
-
COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
por: Meijer, Eelco F. J., et al.
Publicado: (2021) -
Genetic and Phenotypic Characterization of in-Host Developed Azole-Resistant Aspergillus flavus Isolates
por: Buil, Jochem B., et al.
Publicado: (2021) -
Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates
por: Buil, Jochem B., et al.
Publicado: (2018) -
High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
por: Schauwvlieghe, Alexander F. A. D., et al.
Publicado: (2019) -
Invasive Aspergillosis and the Impact of Azole-resistance
por: Bosetti, Davide, et al.
Publicado: (2023)